Demers, M., Sturtevant, S., Guertin, K. R., Gupta, D., Desai, K., Vieira, B. F., . . . Light, D. R. (2021). MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease. Blood Adv.
Dyfyniad Arddull ChicagoDemers, Melanie, et al. "MetAP2 Inhibition Modifies Hemoglobin S to Delay Polymerization and Improves Blood Flow in Sickle Cell Disease." Blood Adv 2021.
Dyfyniad MLADemers, Melanie, et al. "MetAP2 Inhibition Modifies Hemoglobin S to Delay Polymerization and Improves Blood Flow in Sickle Cell Disease." Blood Adv 2021.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.